Karol Bukowski

1.9k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Karol Bukowski is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Karol Bukowski has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Karol Bukowski's work include Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and biological activity (5 papers) and Quinazolinone synthesis and applications (4 papers). Karol Bukowski is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and biological activity (5 papers) and Quinazolinone synthesis and applications (4 papers). Karol Bukowski collaborates with scholars based in Poland, India and Algeria. Karol Bukowski's co-authors include Mateusz Kciuk, Renata Kontek, Katarzyna Woźniak, Beata Marciniak, Katarzyna Mokra, Somdutt Mujwar, Mariusz Mojzych, Daniel Wysokiński, Anna Szymanowska and Agnieszka Marczak and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Cells.

In The Last Decade

Karol Bukowski

15 papers receiving 1.3k citations

Hit Papers

Mechanisms of Multidrug Resistance in Cancer Chemotherapy 2020 2026 2022 2024 2020 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karol Bukowski Poland 8 678 370 227 210 194 16 1.3k
Tina S. Homayouni Canada 4 999 1.5× 430 1.2× 223 1.0× 310 1.5× 242 1.2× 4 1.9k
Sadaf Davudian Iran 6 1.0k 1.5× 419 1.1× 396 1.7× 192 0.9× 174 0.9× 8 1.7k
Mehdi Rajabi United States 21 960 1.4× 263 0.7× 235 1.0× 214 1.0× 205 1.1× 54 1.9k
Rama Rao Malla India 18 750 1.1× 224 0.6× 258 1.1× 194 0.9× 111 0.6× 65 1.4k
Qingbin Cui China 22 1.0k 1.5× 679 1.8× 285 1.3× 229 1.1× 115 0.6× 49 1.8k
Rupa Sanyal India 7 449 0.7× 207 0.6× 103 0.5× 218 1.0× 185 1.0× 14 1.1k
Agnieszka Marczak Poland 19 593 0.9× 369 1.0× 137 0.6× 110 0.5× 128 0.7× 87 1.1k
Shakti Ranjan Satapathy India 22 606 0.9× 285 0.8× 141 0.6× 117 0.6× 76 0.4× 45 1.2k
Prasanthi Karna United States 16 629 0.9× 214 0.6× 255 1.1× 132 0.6× 143 0.7× 21 1.2k
Kang Fang China 22 603 0.9× 171 0.5× 158 0.7× 229 1.1× 122 0.6× 100 1.2k

Countries citing papers authored by Karol Bukowski

Since Specialization
Citations

This map shows the geographic impact of Karol Bukowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Bukowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Bukowski more than expected).

Fields of papers citing papers by Karol Bukowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karol Bukowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Bukowski. The network helps show where Karol Bukowski may publish in the future.

Co-authorship network of co-authors of Karol Bukowski

This figure shows the co-authorship network connecting the top 25 collaborators of Karol Bukowski. A scholar is included among the top collaborators of Karol Bukowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karol Bukowski. Karol Bukowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Bukowska, Bożena, et al.. (2025). Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case Reports of Adverse Drug Interactions in Humans. International Journal of Molecular Sciences. 26(11). 5188–5188. 3 indexed citations
3.
Szwed, Marzena, et al.. (2025). Nanoparticle-Mediated Ferroptosis for Cancer Therapy: Mechanisms and Therapeutic Strategies. PubMed. Volume 18. 445–470. 1 indexed citations
4.
Bukowski, Karol, Aneta Rogalska, & Agnieszka Marczak. (2024). Folate Receptor Alpha—A Secret Weapon in Ovarian Cancer Treatment?. International Journal of Molecular Sciences. 25(22). 11927–11927. 4 indexed citations
5.
Kciuk, Mateusz, Somdutt Mujwar, Beata Marciniak, et al.. (2023). Genotoxicity of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro. International Journal of Molecular Sciences. 24(4). 4053–4053. 4 indexed citations
6.
Bukowski, Karol, Beata Marciniak, Mateusz Kciuk, et al.. (2023). Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Apoptosis, Oxidative Stress, and Cell Cycle Analysis. International Journal of Molecular Sciences. 24(10). 8504–8504. 4 indexed citations
7.
Marciniak, Beata, et al.. (2023). In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments. Cancers. 15(18). 4442–4442. 5 indexed citations
8.
Kciuk, Mateusz, Beata Marciniak, İsmail Çeli̇k, et al.. (2023). Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery—In Vitro and In Silico Evaluation. International Journal of Molecular Sciences. 24(13). 10959–10959. 8 indexed citations
9.
Kciuk, Mateusz, Somdutt Mujwar, Anna Szymanowska, et al.. (2022). Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies. International Journal of Molecular Sciences. 23(11). 5892–5892. 26 indexed citations
10.
Bukowski, Karol, Beata Marciniak, Mateusz Kciuk, Mariusz Mojzych, & Renata Kontek. (2022). Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro. Molecules. 27(12). 3761–3761. 7 indexed citations
11.
Fornal, Emilia, Agata Sumara, Renata Kontek, et al.. (2021). Amino- and polyaminophthalazin-1(2H)-ones: synthesis, coordination properties, and biological activity. Beilstein Journal of Organic Chemistry. 17. 558–568. 5 indexed citations
12.
Kciuk, Mateusz, Karol Bukowski, Beata Marciniak, & Renata Kontek. (2020). Advances in DNA Repair—Emerging Players in the Arena of Eukaryotic DNA Repair. International Journal of Molecular Sciences. 21(11). 3934–3934. 15 indexed citations
13.
Bukowski, Karol, Mateusz Kciuk, & Renata Kontek. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. International Journal of Molecular Sciences. 21(9). 3233–3233. 1193 indexed citations breakdown →
14.
Bukowski, Karol, Daniel Wysokiński, Katarzyna Mokra, & Katarzyna Woźniak. (2019). DNA damage and methylation induced by organophosphate flame retardants: Tris(2-chloroethyl) phosphate and tris(1-chloro-2-propyl) phosphate in human peripheral blood mononuclear cells. Human & Experimental Toxicology. 38(6). 724–733. 20 indexed citations
15.
Mokra, Katarzyna, Karol Bukowski, & Katarzyna Woźniak. (2018). Effects of tris(1-chloro-2-propyl)phosphate and tris(2-chloroethyl)phosphate on cell viability and morphological changes in peripheral blood mononuclear cells (in vitro study). Human & Experimental Toxicology. 37(12). 1336–1345. 15 indexed citations
16.
Bukowski, Karol & Katarzyna Woźniak. (2017). Polymorphism of genes encoding proteins of DNA repairvs. occupational and environmental exposure to lead, arsenic and pesticides. Medycyna Pracy. 69(2). 225–235. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026